RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/17950244http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/17950244http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/17950244http://www.w3.org/2000/01/rdf-schema#comment"PLAGL2 (Pleomorphic Adenoma Gene Like 2) is an oncoprotein involved in various malignancies including lipoblastomas, hepatoblastomas, and acute myeloid leukemia. Although PLAGL2 is known to mainly act as a transcription factor, other functions which may contribute to its oncogenic potential are not clear. Pirh2 (P53 induced RING-H2 protein) is a p53 inducible E3 ligase involved in the ubiquitination of p53, while the mechanisms to regulate its activities are largely unknown. In this study, we show for the first time that Pirh2 forms dimers through its N- and C-terminus in cells and Pirh2 dimers interact with PLAGL2. The interaction between PLAGL2 and Pirh2 dimers prevents proteasomal degradation of Pirh2. This study thus uncovers a novel function of PLAGL2 as an oncoprotein through regulating the stability of Pirh2. Given the importance of Pirh2 in regulating p53 stability, its interaction with PLAGL2 may provide valuable therapeutic targets in treating Pirh2-overexpression malignancies."xsd:string
http://purl.uniprot.org/citations/17950244http://purl.org/dc/terms/identifier"doi:10.1016/j.bbrc.2007.10.003"xsd:string
http://purl.uniprot.org/citations/17950244http://purl.org/dc/terms/identifier"doi:10.1016/j.bbrc.2007.10.003"xsd:string
http://purl.uniprot.org/citations/17950244http://purl.uniprot.org/core/author"Zheng G."xsd:string
http://purl.uniprot.org/citations/17950244http://purl.uniprot.org/core/author"Zheng G."xsd:string
http://purl.uniprot.org/citations/17950244http://purl.uniprot.org/core/author"Ning J."xsd:string
http://purl.uniprot.org/citations/17950244http://purl.uniprot.org/core/author"Ning J."xsd:string
http://purl.uniprot.org/citations/17950244http://purl.uniprot.org/core/author"Yang Y.-C."xsd:string
http://purl.uniprot.org/citations/17950244http://purl.uniprot.org/core/author"Yang Y.-C."xsd:string
http://purl.uniprot.org/citations/17950244http://purl.uniprot.org/core/date"2007"xsd:gYear
http://purl.uniprot.org/citations/17950244http://purl.uniprot.org/core/date"2007"xsd:gYear
http://purl.uniprot.org/citations/17950244http://purl.uniprot.org/core/name"Biochem. Biophys. Res. Commun."xsd:string
http://purl.uniprot.org/citations/17950244http://purl.uniprot.org/core/name"Biochem. Biophys. Res. Commun."xsd:string
http://purl.uniprot.org/citations/17950244http://purl.uniprot.org/core/pages"344-350"xsd:string
http://purl.uniprot.org/citations/17950244http://purl.uniprot.org/core/pages"344-350"xsd:string
http://purl.uniprot.org/citations/17950244http://purl.uniprot.org/core/title"PLAGL2 controls the stability of Pirh2, an E3 ubiquitin ligase for p53."xsd:string
http://purl.uniprot.org/citations/17950244http://purl.uniprot.org/core/title"PLAGL2 controls the stability of Pirh2, an E3 ubiquitin ligase for p53."xsd:string
http://purl.uniprot.org/citations/17950244http://purl.uniprot.org/core/volume"364"xsd:string
http://purl.uniprot.org/citations/17950244http://purl.uniprot.org/core/volume"364"xsd:string
http://purl.uniprot.org/citations/17950244http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/17950244
http://purl.uniprot.org/citations/17950244http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/17950244
http://purl.uniprot.org/citations/17950244http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/17950244
http://purl.uniprot.org/citations/17950244http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/17950244